Bank of New York Mellon’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-141,284
| Closed | -$226K | – | 4137 |
|
|
2025
Q1 | $226K | Buy |
141,284
+201
| +0.1% | +$322 | ﹤0.01% | 3814 |
|
|
2024
Q4 | $508K | Sell |
141,083
-2,210
| -2% | -$7.96K | ﹤0.01% | 3495 |
|
|
2024
Q3 | $817K | Sell |
143,293
-47,468
| -25% | -$271K | ﹤0.01% | 3248 |
|
|
2024
Q2 | $881K | Buy |
+190,761
| New | +$881K | ﹤0.01% | 3266 |
|
|
2024
Q1 | – | Sell |
-20,682
| Closed | -$117K | – | 4172 |
|
|
2023
Q4 | $117K | Sell |
20,682
-189
| -0.9% | -$1.07K | ﹤0.01% | 4055 |
|
|
2023
Q3 | $38.8K | Sell |
20,871
-1,410
| -6% | -$2.62K | ﹤0.01% | 4177 |
|
|
2023
Q2 | $61.3K | Sell |
22,281
-129,276
| -85% | -$356K | ﹤0.01% | 4138 |
|
|
2023
Q1 | $476K | Sell |
151,557
-945
| -0.6% | -$2.97K | ﹤0.01% | 3510 |
|
|
2022
Q4 | $900K | Buy |
152,502
+666
| +0.4% | +$3.93K | ﹤0.01% | 3244 |
|
|
2022
Q3 | $1.33M | Buy |
151,836
+18,332
| +14% | +$161K | ﹤0.01% | 3067 |
|
|
2022
Q2 | $1.01M | Buy |
133,504
+6,432
| +5% | +$48.5K | ﹤0.01% | 3205 |
|
|
2022
Q1 | $3.08M | Buy |
127,072
+1,601
| +1% | +$38.8K | ﹤0.01% | 2690 |
|
|
2021
Q4 | $4.04M | Buy |
125,471
+12,873
| +11% | +$414K | ﹤0.01% | 2580 |
|
|
2021
Q3 | $5.03M | Buy |
112,598
+28,053
| +33% | +$1.25M | ﹤0.01% | 2480 |
|
|
2021
Q2 | $3.2M | Buy |
84,545
+55,028
| +186% | +$2.08M | ﹤0.01% | 2712 |
|
|
2021
Q1 | $1.09M | Buy |
29,517
+1,176
| +4% | +$43.5K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $939K | Buy |
+28,341
| New | +$939K | ﹤0.01% | 3277 |
|